Detected ·
Latigo Biotherapeutics, Inc.
——
Latigo Biotherapeutics, Inc. has gone public on Nasdaq (LTGO), advancing its clinical-stage pipeline of non-opioid pain therapies. Foresite Capital, an early Series A investor, supported the company through each subsequent financing round.
- Website
- www.latigobio.com
- linkedin.com/company/latigobio
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-08 08:03:11 UTC
- Signal ID
- 4010ebf7-1722-41f0-ad11-7397ad994322
As the API returns it
{
"id": "4010ebf7-1722-41f0-ad11-7397ad994322",
"created_at": "2026-08-08T08:03:11.992590Z",
"company_name": "Latigo Biotherapeutics, Inc.",
"company_website_url": "www.latigobio.com",
"company_linkedin_url": "https://www.linkedin.com/company/latigobio",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Latigo Biotherapeutics, Inc. has gone public on Nasdaq (LTGO), advancing its clinical-stage pipeline of non-opioid pain therapies. Foresite Capital, an early Series A investor, supported the company through each subsequent financing round.*"
}